NCT07271927 Whole-Body Photobiomodulation for Motor and Cognitive Changes in Parkinson's Disease
| NCT ID | NCT07271927 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pusan National University Yangsan Hospital |
| Condition | PARKINSON DISEASE (Disorder) |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2025-02-12 |
| Primary Completion | 2025-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2025-02-12 with a primary completion date of 2025-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to exploratorily evaluate the extent of motor and cognitive changes, as well as the safety, resulting from approximately 10 weeks of whole-body photobiomodulation (PBM) therapy (about three sessions per week, once daily, 20 minutes per session) in patients with Parkinson's disease.
Eligibility Criteria
Inclusion Criteria: * Individuals diagnosed with Parkinson's disease at Hoehn and Yahr stages 1-3 based on medical history and examination * Adults aged 40 years or older * Individuals able to walk independently Exclusion Criteria: * Individuals with severe cognitive impairment (Korean Mini-Mental State Examination \[K-MMSE\] score ≤ 9) making it difficult to understand and perform tasks * Patients with dementia other than Parkinson's disease dementia * Individuals with implanted medical or other electronic devices * Individuals with severe neuropsychiatric disorders * Individuals treated for alcohol dependence within 6 months prior to screening * Individuals with a history of suicide attempts * Individuals with a history of seizures * Individuals experiencing dyspnea while sitting at rest * Individuals with visual impairment preventing them from reading ordinary text even with corrective lenses * Individuals with hearing impairment preventing them from understanding conversation even with a hearing aid * Individuals who have participated in two or more clinical trials in the same year or in another clinical trial within the past 6 months * Women and men of childbearing potential who are planning pregnancy during the trial or who do not agree to use appropriate contraceptive methods * Pregnant or breastfeeding women * Individuals deemed medically inappropriate for participation by the principal investigator or study staff based on clinically significant findings not otherwise specified above
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07271927 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying PARKINSON DISEASE (Disorder). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07271927 currently recruiting?
Yes, NCT07271927 is actively recruiting participants. Contact the research team at zisoo@pusan.ac.kr for enrollment information.
Where is the NCT07271927 trial being conducted?
This trial is being conducted at Yangsan, South Korea.
Who is sponsoring the NCT07271927 clinical trial?
NCT07271927 is sponsored by Pusan National University Yangsan Hospital. The trial plans to enroll 15 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.